Q&A: CMO and de­vel­op­ment chief Di­et­mar Berg­er says Sanofi is 'right there at the table' on di­ver­si­ty ef­forts

Sanofi is de­but­ing its newest di­ver­si­ty ini­tia­tive to­day, a part­ner­ship with his­tor­i­cal­ly Black uni­ver­si­ty Howard Uni­ver­si­ty to help launch the next gen­er­a­tion of sci­en­tists — and Sanofi em­ploy­ees. The pro­gram with Howard’s phar­ma­cy school in­cludes the added ex­tra step of promis­ing jobs at Sanofi to suc­cess­ful can­di­dates.

Help­ing to over­see the pro­gram is Di­et­mar Berg­er, Sanofi’s chief med­ical of­fi­cer and glob­al head of de­vel­op­ment. He joined Sanofi more than three years ago af­ter a short stint at Atara Bio­ther­a­peu­tics, but be­fore that had a long ca­reer in big bio­phar­ma drug de­vel­op­ment. Berg­er, a hema­tol­o­gist-on­col­o­gist, led Genen­tech’s hema­tol­ogy and on­col­o­gy clin­i­cal de­vel­op­ment for six and a half years be­fore Atara. Be­fore that, he led Bay­er’s on­col­o­gy de­vel­op­ment in head can­cers and worked at Am­gen in clin­i­cal de­vel­op­ment for more than 10 years in a va­ri­ety of on­col­o­gy roles.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER